Literature DB >> 2991325

Follicle-stimulating hormone-secreting pituitary adenomas.

A Beckers, A Stevenaert, K Mashiter, G Hennen.   

Abstract

This retrospective study concerns 40 patients with an apparently nonsecretory pituitary adenoma who were operated on during an 11-yr period from 1971 to 1981. Among them, 6 men had elevated serum FSH levels. LH levels were normal in 5 and slightly elevated in 1. Testosterone levels were low in 2 patients and within normal limits in 2 others. Sexual impotency had developed from 6 months to 1 yr before surgery in all patients. Primary hypogonadism could be eliminated on clinical grounds (recent onset of hypogonadism, previous fertility of 5 of the 6, and postoperative improvement). After transsphenoidal adenomectomy, FSH levels returned to normal values in all, and clinical recovery occurred in most patients. Tumor tissue obtained at operation stained positively for the gonadotropins, but was negative for other pituitary hormones in all patients. The most probable explanation for these findings was that the tumors were responsible for the elevated FSH secretion. This explanation is supported by the immunocytochemical identification of gonadotropin-containing cells in the tumors. We conclude that these 6 men from a series of 40 patients who presented with pituitary tumor but no GH, PRL, or ACTH hypersecretion had primary gonadotropinomas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991325     DOI: 10.1210/jcem-61-3-525

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.

Authors:  Mansur E Shomali; Laurence Katznelson
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

2.  Application of biotinylated oligonucleotide probes to the detection of pituitary hormone mRNA using northern blot analysis, in situ hybridization at the light- and electron-microscope levels.

Authors:  A Matsuno; A Teramoto; S Takekoshi; H Utsunomiya; Y Ohsugi; S Kishikawa; R Y Osamura; T Kirino; R V Lloyd
Journal:  Histochem J       Date:  1994-10

3.  Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.

Authors:  R Abs; P M Parizel; A Beckers
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

4.  HGH, PRL, and ACTH Gene Expression in Clinically Nonfunctioning Adenomas Detected with Nonisotopic In Situ Hybridization Method.

Authors:  Akira Matsuno; Akira Teramoto; Susumu Takekoshi; Naoko Sanno; R. Yoshiyuki Osamura; Takaaki Kirino
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

5.  Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.

Authors:  P Chanson; N Lahlou; A Warnet; M Roger; G Sassolas; J Lubetzi; G Schaison; P Bouchard
Journal:  J Endocrinol Invest       Date:  1994-02       Impact factor: 4.256

6.  Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.

Authors:  C Blanco; T Lucas; J Alcañiz; N Davila; P Serrano; B Barcelò; J Estrada
Journal:  J Endocrinol Invest       Date:  1994-02       Impact factor: 4.256

Review 7.  Updating the Landscape for Functioning Gonadotroph Tumors.

Authors:  Georgia Ntali; Cristina Capatina
Journal:  Medicina (Kaunas)       Date:  2022-08-08       Impact factor: 2.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.